Inactive Instrument

Calendar GENFIT Euronext Paris

Stocks

FR0004163111

Biotechnology & Medical Research

End-of-day quote Euronext Paris
- ^EUR	-

07-03	Genfit soars on news of U.S. reimbursement for a product
07-03	Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement	MT

Upcoming events on GENFIT

29/09/2026	Earnings release - Q2 2026
05/11/2026	Sales and Revenue Release - Q3 2026

Past events on GENFIT

15/06/2026	Présentation aux Actionnaires / Analystes	09:00
15/06/2026	Extraordinary General Meeting
15/06/2026	Annual General Meeting
21/05/2026	Sales and Revenue Release - Q1 2026
02/04/2026	Earnings release - Annual 2025
26/02/2026	Sales and Revenue Release - Annual 2025
20/11/2025	Sales and Revenue Release - Q3 2025
22/09/2025	Earnings release - Q2 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million EUR	Released Forecast Spread	38,2 61,6 -38.07%	70,9 77,4 -8.31%	71,1 66,8 6.43%	100	124	147
EBITDA Million EUR	Released Forecast Spread	-24,9 -38,2 34.76%	5,01 29,4 -82.98%	-51,8 -41,3 -25.29%	28,1	60,7	72,1
EBIT Million EUR	Released Forecast Spread	-26,6 -25,4 -4.81%	3,28 16,8 -80.47%	-4,50 -5,35 15.87%	34,2	67,0	84,9
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-28,5 5,23 -645.39%	1,85 2,70 -31.59%	-86,5 -5,35 -1515.44%	42,7	126	122
Net income Million EUR	Released Forecast Spread	-28,9 -21,9 -32.17%	1,51 20,1 -92.51%	-86,0 -8,30 -935.48%	22,9	6,80	33,3
EPS EUR	Released Forecast Spread	-0,58 -0,56 -3.66%	0,03 0,26 -88.24%	-1,72 -0,10 -1656.36%	0,39	0,15	1,10
Announcement Date		04/04/24	24/04/25	02/04/26	-

Quarterly results

Fiscal Period	December	2024 S1	2024 Q4	2024 S2	2025 Q1	2025 S1	2025 S2	2026 Q1	2026 S1	2026 S2
Net sales Million EUR	Released Forecast Spread	61,2 48,3 26.79%	11,2 7,30 53.96%	9,74 23,1 -57.77%	2,80 133 -97.89%	35,7 98,6 -63.81%	35,4 42,1 -15.81%	9,60 9,50 1.05%	33,4	40,8
EBIT Million EUR	Released Forecast Spread	31,2 21,1 48.11%		-27,9 -26,8 -4.26%		0,08 57,9 -99.87%	-4,50 4,40 -202.29%
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	30,3 22,8 32.93%		-28,5 -27,6 -3.27%		-10,1 57,8 -117.49%	-76,4 3,30 -2415.06%
Net income Million EUR	Released Forecast Spread	30,3 17,2 76.02%		-28,8 -11,5 -150.47%		-9,96 51,4 -119.37%	-76,0 0,85 -9042.59%		-0,80	5,30
EPS EUR	Released Forecast Spread	0,53 0,49 8.16%		-0,50 -0,55 9.09%		-0,20 2,18 -109.17%
Announcement Date		19/09/24	24/04/25	24/04/25	22/05/25	22/09/25	02/04/26	21/05/26	-	-

Upcoming sector events for GENFIT

07/09/2026	PELL BIO-MED TECHNOLOGY CO., LTD.	Significant Split/Dividend	05:00
08/09/2026	JOINN LABORATORIES(CHINA)CO.,LTD.	Earnings presentation	02:00
08/09/2026	BEAM THERAPEUTICS INC.	Information meeting	12:00
08/09/2026	ATAIBECKLEY INC.	Extraordinary General Meeting	16:00
08/09/2026	INHIBRX BIOSCIENCES, INC.	Information meeting	13:00
08/09/2026	ARTIVA BIOTHERAPEUTICS, INC.	Annual General Meeting
08/09/2026	ARTIVA BIOTHERAPEUTICS, INC.	Présentation aux Actionnaires / Analystes	22:00
09/09/2026	BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.	Earnings presentation	09:30
10/09/2026	PHARMARON BEIJING CO., LTD.	Extraordinary General Meeting	07:30
10/09/2026	GENUS PLC	Earnings release - Annual 2026

Past sector events for GENFIT

04/09/2026	IONIS PHARMACEUTICALS, INC.	Information meeting	15:00
04/09/2026	PYC THERAPEUTICS LIMITED	Information meeting	01:01
03/09/2026	ONESOURCE SPECIALTY PHARMA LIMITED	Présentation aux Actionnaires / Analystes
02/09/2026	IMMUNOVANT, INC.	Annual General Meeting	18:00
02/09/2026	IMMUNOVANT, INC.	Présentation aux Actionnaires / Analystes	18:00
01/09/2026	DEFINIUM THERAPEUTICS, INC.	Information meeting	18:00
31/08/2026	PROTAGONIST THERAPEUTICS, INC.	Information meeting	13:30
31/08/2026	NANJING LEADS BIOLABS CO., LTD.	Board of Directors Meeting
31/08/2026	NANJING LEADS BIOLABS CO., LTD.	Earnings release - Q2 2026
31/08/2026	IMPACT THERAPEUTICS, INC	Earnings release - Q2 2026

The best tools reserved for subscribers to boost the performance of your investments!